BI
Bioceres Crop Solutions Corp.
BIOX · NASDAQ
$0.43 +1.14% (+$0.00)
1M +21.20%
Market Cap $27.4M
P/E Ratio -
Div. Yield -
ROE 154.24%
Bulios Fair Price
$0.56
29.1% upside
Current Price
$0.43
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BIOX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.10x
P/FCF 0.50x
P/B 0.43x
Growth
53 /100
Stable Rev. growth 0.49%
Book val. growth 27.23%
EPS growth N/A
Profitability
53 /100
Moderate Gross margin 36.71%
FCF margin 20.77%
Net margin 95.02%
Quality
10 /100
Poor ROIC 0.60%
Asset turnover 0.50x
ROE 154.24%
Debt
6 /100
High Debt/Equity 3.76x
Int. coverage -1.21x
Current ratio 0.84x
Stability
24 /100
Unstable Beta 0.40x
Profitable years 0
Rev. volatility 28.73%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BIOX
Online
Sector
Basic Materials
Industry
Agricultural Inputs
CEO
Federico Trucco
Employees
751
Headquarters
Rosario
Upcoming events
17 NOV
Earnings
Upcoming earnings report